Profilo
Currently, Dámaso Molero is the Chief Executive Officer at 3P Biopharmaceuticals SL since 2006.
Formerly, the roles included Principal at Shionogi & Co., Ltd., Syntex, Inc., Glaxo, Inc., and Roche Holding AG.
Education includes undergraduate and MBA degrees from the University of Navarra.
Posizioni attive di Dámaso Molero
| Società | Posizione | Inizio |
|---|---|---|
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Amministratore Delegato | 01/04/2007 |
Precedenti posizioni note di Dámaso Molero
| Società | Posizione | Fine |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Corporate Officer/Principal | - |
Glaxo, Inc. | Corporate Officer/Principal | - |
Formazione di Dámaso Molero
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Shionogi & Co., Ltd.
Shionogi & Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of pharmaceuticals & diagnostic reagents | Health Technology |
University of Navarra
University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
3P Biopharmaceuticals SL
3P Biopharmaceuticals SL Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins and biological molecules | Health Technology |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Glaxo, Inc. |
















